Hi murphy,
1. If a Pharma takes over.... they get everything.
I cannot see them paying out the figures bandied about, without owning it all.
2. Synergies with other forms of chemo.... and we are talking about "combination with other drugs" is the current journey virotherapy is experiencing...... all part of trying to achieve an attractive product for a Pharma to pounce upon. It may well eventuate that Cavatak will be acquired by a Pharma who will then embark upon further trials in combination with other drugs.
3. The specifics of Amgen's experience.... from my memory, was that follow through trialling did not achieve as good a result as they would have liked.... albeit relatively successful. Cyberguy is of the opinion Amgen wont get burnt twice.... and I know where he is coming from.... but I feel Cavatak is a better product than T-Vec. I pray Pharmas agree with me. The almighty advantage Cavatak has over the rest of the field is the almost non existent side effects. Huge advantage!!
Add to My Watchlist
What is My Watchlist?